Halozyme (HALO) Debt/EBITDA US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | 0.20 | 0.49 | 3.62 | 3.68 | 2.75 | 2.08 | |||
Changes by years, y/y, % | -27% | +143% | +636% | +2% | -25% | -3.5% |
Halozyme. Debt/EBITDA
Halozyme. Debt/EBITDA, changes, %
Halozyme (HALO) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
Debt/EBITDA | 3.03 | 2.71 | 2.79 | 2.32 | 2.08 | 2.08 | ||
Changes by years, y/y, % | -25% | -36% | -23% | -41% | -32% | |||
Changes by quarters, q/q, % | -23% | -11% | +3% | -17% | -10% |